Connect with us

Business

General Cannabis Corp (OTCMKTS:CANN) Introduces ‘GCER’

Published

on

General Cannabis Corp

In last trading session, the stock price of General Cannabis Corp (OTCMKTS:CANN) jumped more than 6% to close the day at $1.40. The gains came at a share volume of 144,133 compared to average share volume of 282,173.

The buzz

General Cannabis reported that it has launched a new segment of public market research services named as General Cannabis Equity Research. Robert Frichtel, the CEO said that GCER is the first step in the establishing of an equity research segment and leverages the unique market insight that the company benefits from industry position.

Due to the breadth of company’s team and corporate platform, the management gain unique knowledge that they believe will bring value in making informed investment decisions. General Cannabis Equity Research will offer detailed and unbiased research on publicly traded firms.

Michael Feinsod, the Executive Chairman of General Cannabis, said that they recorded total absence of a trustworthy research on public firms in the sector. While there are several public firms that claim to function in the cannabis industry, there is no reliable source of public company and industry research. The void results in market uncertainty and has restricted access to funds for cannabis related firms. General Cannabis management intends to fill that void.

The plans

General Cannabis is currently engaging individuals for the dedicated research team and plans to introduce comprehensive GCER services in July. The approach to research be based on a high value of management quality and intrinsic value. They will assess cannabis investments as an M&A specialist carries out the assessment.

The evaluation of the individual cannabis firms will be led by economic realities of the cannabis industry and its continuously changing dynamics. The company projects the first reports to be released in July 2016, and it will only include the firms that are current in their regulatory filing requirements for the quarter ended on March 31, 2016.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of MMJReporter.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure

BRANDS

DETAILS

SCORE

PRODUCT SITES

  • Certified Organic
  • Made In U.S.A
  • Purity Promise
  • Price From $49

9.8

30% OFF Today! “30 0FF”

  • All Natural
  • Made In U.S.A
  • Lab Tested
  • Price From $69

9.7

  • All Natural
  • Made In U.S.A
  • Dissolvable Oral
  • Price From $99

9.6

  • All Natural
  • Made In U.S.A
  • Oral Mist
  • Price From $39

9.5

BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Purity Promise
  • Price From $49
SCORE

9.8

PRODUCT SITE
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Lab Tested
  • Price From $69
SCORE

9.7

PRODUCT SITE VIEW PRODUCTS
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Dissolvable Oral
  • Price From $99
SCORE

9.6

PRODUCT SITE VIEW PRODUCTS
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Oral Mist
  • Price From $39
SCORE

9.5

PRODUCT SITE VIEW PRODUCTS
Advertisement
Advertisement

Symbol        Alert        High        Gain

 

  VBIO          $0.67       $4.10      500%

  IMLFF        $0.11       $0.57      400%

  CMXC        $0.25       $0.45      80%

  REPCF       $0.54       $0.79      48%

 

Get Your Latest Winner Delivered to Your Inbox!

FREE

For The Next 48 Hours

Advertisement
Advertisement
Advertisement
Advertisement
Advertisement